Featured Research

from universities, journals, and other organizations

San Francisco Study Explains Prostate Cancer Resistance To Hormone Therapy, Offers Possible Solution

Date:
March 7, 2002
Source:
University Of California - San Francisco
Summary:
Hormone therapy is often used to treat prostate cancer, but these drugs that mimic the effects of estrogen do not work on many late-stage cancers. Now San Francisco Veterans Affairs Medical Center researchers say they can explain the failure of these drugs, and suggest a way to restore their potency.

Hormone therapy is often used to treat prostate cancer, but these drugs that mimic the effects of estrogen do not work on many late-stage cancers. Now San Francisco Veterans Affairs Medical Center researchers say they can explain the failure of these drugs, and suggest a way to restore their potency.

The study, published in the latest issue of Journal of the National Cancer Institute, reveals that late-stage prostate cancer is unresponsive to hormone therapy because the cells have shut down genes for the estrogen receptors where the drugs act.

The genes are switched off by a process called hypermethylation, a well-known process in which numerous methyl groups are attached to the regulatory stretches of DNA near the beginning of the gene, said the study’s lead author Raj Dahiya, PhD, director of the urology research center at SFVAMC, and UCSF professor of urology.

“This hypermethylation explains why we see inactivation of estrogen receptors in prostate cancer, and why hormone therapy no longer works in many cases,” said Dahiya, whose research was supported by funding from the Department of Veterans Affairs, and by grants from the National Institutes of Health, which were managed by Northern California Institute for Research and Education (NCIRE).

In their study, Dahiya’s group first showed that normal prostate cells were free of methylation at estrogen receptor genes and the cells displayed plenty of estrogen receptors. However, cells from late-stage prostate cancers had hypermethylation on their estrogen receptor genes and the cells displayed no estrogen receptors. Cells from an early stage prostate cancer have some methylation, which leads to intermediate activity, and the generation of relatively few estrogen receptors, Dahiya said.

Studies of prostate tissue taken from 38 prostate cancer patients further strengthened the link between hypermethylation and prostate cancer. The researchers found that nearly all tissue samples from tumors had hypermethylation on their estrogen receptor genes, but tissue samples from healthy sections of the prostate showed no such methylation.

Genetics researchers have studied hypermethylation for years, Dahiya said, and they know how to prevent it. This raises the hope that tumors that are resistant to hormone therapy could be made vulnerable again.

In fact, Dahiya and his colleagues treated some of their prostate cancer cells growing in culture with a drug that reverses methylation, and the cells once again switched on their estrogen receptor genes.

“People are testing de-methylating agents in clinical trials for several other cancers. In prostate cancer we could inject these drugs directly into the prostate, and that might restore the lost effectiveness of hormone therapy,” he said.

This study should serve as the basis for future clinical trials of demethylating agents for prostate cancer, said Peter Carroll, MD, chair and professor of the UCSF Department of Urology.

Co-investigators on the study included Masahiro Sasaki, MD, PhD, a research scientist at UCSF/SFVAMC; Yuichiro Tanaka, PhD, associate investigator at UCSF/SFVAMC; Geetha Perinchery MD, fellow at UCSF/SFVAMC; Abhipsa Dharia, MD, fellow at UCSF/SFVAMC; Ioulia Kotcherguina, MD, fellow at UCSF/SFVAMC; and Sei Ichiro Fujimoto, MD, PhD, professor of obstetrics and gynecology at Hokkaido University, Japan.

NCIRE is one of the fastest growing medical research groups in the nation. Founded in 1988, NCIRE now manages more than $30 million in funding from organizations such as the National Institutes of Health, Department of Veterans Affairs, the National Aeronautics and Space Administration, and the National Science Foundation. Based at the San Francisco VA Medical Center, NCIRE is the largest of the 80 congressionally authorized VA research corporations.

The San Francisco Veterans Affairs Medical Center has been a primary affiliate of University of California, San Francisco since 1974. The UCSF School of Medicine and the SFVAMC collaborate to provide education and training programs for medical students and residents at SFVAMC. SFVAMC maintains full responsibility for patient care and facility management of the medical center. Physicians at SFVAMC are employed by the Department of Veterans Affairs and also hold UCSF faculty appointments.


Story Source:

The above story is based on materials provided by University Of California - San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University Of California - San Francisco. "San Francisco Study Explains Prostate Cancer Resistance To Hormone Therapy, Offers Possible Solution." ScienceDaily. ScienceDaily, 7 March 2002. <www.sciencedaily.com/releases/2002/03/020307073335.htm>.
University Of California - San Francisco. (2002, March 7). San Francisco Study Explains Prostate Cancer Resistance To Hormone Therapy, Offers Possible Solution. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2002/03/020307073335.htm
University Of California - San Francisco. "San Francisco Study Explains Prostate Cancer Resistance To Hormone Therapy, Offers Possible Solution." ScienceDaily. www.sciencedaily.com/releases/2002/03/020307073335.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins